Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Nurses’ Knowledge and Attitudes towards Biosimilar Medicines as Part of Evidence-Based Nursing Practice—International Pilot Study within the Project Biosimilars Nurses Guide Version 2.0

Bibliographic Data

ID15514243
AuthorsAdriano Friganović (0000-0002-9528-6464, University Hospital Centre Zagreb), Wioletta Mędrzycka‐Dąbrowska (0000-0001-8377-4893, Gdańsk Medical University, corresponding author), Sabina Krupa (0000-0002-3002-3153, Rzeszów University), Ber Oomen (European Specialist Nurses Organization, 6821 HR Arnhem, The Netherlands), Nico Decock (Nurse Anaesthesia School, University Hospital of Lille, 111 Rue Charles Debierre, 59000 Lille, France), Alessandro Stievano (0000-0003-3508-2352, University of Rome Tor Vergata)
Year2022
Volume19
Issue16
Pages10311-10311
Publication date2022-08-19
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueInternational Journal of Environmental Research and Public Health (JOURNAL)
Journal identifiersISSN: 1661-7827 • E-ISSN: 1660-4601
PublisherMultidisciplinary Digital Publishing Institute (PUBLISHER • CH)
DOI10.3390/ijerph191610311
PMID36011946
OpenAlexW4293778344
LanguageEN
References cited19

Introduction: The increasing availability of biosimilars can increase patient access to these drugs and reduce the economic burden. Nurses play a key role in the education, administration, pharmacovigilance and management of the side effects of biosimilars. The aim of this study was to assess the knowledge and attitudes of nurses towards biosimilar drugs in different countries. Methods: An international cross-sectional study was conducted from November 2021 to February 2022. The survey was carried out using Computer-Assisted Web Interview (CAWI), sent by the CAWI panel via the website. Results: The results showed that nurses with a greater level of education felt most knowledgeable about biosimilars (χ2 = 105.813, df = 2, p < 0.001). One-third of nurses with a doctorate and a second degree said biosimilars are used in their workplace (χ2 = 48.169, df = 4, p < 0.001); most nurses with a second degree said that they had never heard of biosimilars (41%). Doctorate-level nurses thought knowledge is the key factor to increasing biosimilar uptake (97%). Conclusions: Nurses are not knowledgeable about biosimilars. Most would like to participate in training on biosimilars. This is a very important topic, because biosimilars are constantly evolving in medicine

Adverse effect · Biosimilar · Family medicine · Pharmacovigilance · Biosimilars and Bioanalytical Methods · Medicine · Nursing · Pharmaceutical studies and practices · Safe Handling of Antineoplastic Drugs · Internal Medicine · Pharmacology

  • The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement

    Open Access•Erik Von Elm, David G Altman et al.•PLoS Medicine•2007

  • The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement

    Open Access•Erik Von Elm, David G Altman et al.•International Journal of Surgery•2014

Citation velocityhistorical
Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae